• Milton W. TaylorEmail author


The herpes family of viruses is associated with a large number of infectious diseases, including some types of cancer, such as Burkitt’s lymphoma, and Kaposi sarcoma and with sexually transmitted diseases such as genital blisters. (HSV-2), and chickenpox. The virus can exist in an active phase or latent phase, and can manifest itself in different forms and pathological situations. Chickenpox can reappear many years later as shingles, in particular when the immune system is compromised. Epstein Barr-virus infection can lead to various cancers depending on environmental and genetic factors, and in the lytic form as mononucleosis. Burkitt’s lymphoma is confined to areas of Africa with high malaria prevalence and is characterized at the genetic level by a gene translocation. HSV-8 infection results in Kaposi sarcoma and is found in individuals suffering from AIDS, although now recognized as a cancer in non-AIDS populations in Africa. There has been a dramatic increase in genital herpes during the last few years.


Herpes Zoster Herpes Virus Genital Herpes Infectious Mononucleosis Zoster Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Burkitt, D. P. (1983). The discovery of Burkitt’s lymphoma. Cancer, 51(10), 1777–1786.PubMedCrossRefGoogle Scholar
  2. 2.
    Henle, W., & Henle, G. (1969). The relation between the Epstein-Barr virus and infectious mononucleosis, Burkitt’s lymphoma and cancer of the postnasal space. East African Medical Journal, 46(7), 402–406.PubMedGoogle Scholar
  3. 3.
    Cohen, J. (2003). Epstein-Barr virus: An oncogenic human herpes virus (6th ed.). Hamilton, Ontario, Canada.Google Scholar
  4. 4.
    Ascherio, A., & Munger, K. L. (2010). Epstein-Barr virus infection and multiple sclerosis: A review. Journal of Neuroimmune {Harmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 5(3), 271–277.Google Scholar
  5. 5.
    Scadden, D. T. (2003). Kaposi’s sarcoma (6th ed.). Hamilton, Ontario, Canada.Google Scholar
  6. 6.
    Looker, K. J., Garnett, G. P., & Schmid, G. P. (2008). An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bulletin of the World Health Organization, 86(10), 805–812A.PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Takahashi, M., Otsuka, T., Okuno, Y., Asano, Y., & Yazaki, T. (1974). Live vaccine used to prevent the spread of varicella in children in hospital. Lancet, 2(7892), 1288–1290.PubMedCrossRefGoogle Scholar
  8. 8.
    Gershon, A. A. (2007). Varicella-zoster vaccine. In A. Arvin, G. Campadelli-Fiume, E. Mocarski, P. S. Moore, B. Roizman, R. Whitley, & K. Yamanishi (Eds.), Human herpesviruses: Biology, therapy, and immunoprophylaxis. Cambridge: Cambridge University Press.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2014

Authors and Affiliations

  1. 1.Indiana UniversityBloomingtonUSA

Personalised recommendations